Wordt geladen...
CYP4F2 genetic variant alters required warfarin dose
Warfarin is an effective, commonly prescribed anticoagulant used to treat and prevent thrombotic events. Because of historically high rates of drug-associated adverse events, warfarin remains underprescribed. Further, interindividual variability in therapeutic dose mandates frequent monitoring until...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2288721/ https://ncbi.nlm.nih.gov/pubmed/18250228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-11-122010 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|